These include the up-regulation of tTG protein and/or mRNA levels downstream of growth factors and cytokines, such as EGF in breast cancer cells, TGF-β in ovarian cancer and dermal fibroblasts, and IL-6 in hepatoblastoma cells [2, 4, 11–13]. The gene discussed is TGM2; the disease is ovarian cancer.